Loading insider details...
Latest Form 4 (Jun 3, 2026): Purchase of 29,000 OTLK shares, $24.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 29,000 | $24.1K |
| May 27, 2026 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 34,000 | $15.0K |
| Oct 3, 2025 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 286,734 | n/a |
| Oct 4, 2024 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 56,636 | n/a |
| Mar 29, 2024 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 1,882 | $22.2K |
| Mar 8, 2024 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 94,441 | n/a |
| Oct 5, 2023 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 358,337 | n/a |
| Mar 31, 2023 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 41,065 | n/a |
| Oct 11, 2022 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 29,743 | $38.4K |
| Oct 7, 2022 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 71,998 | n/a |